Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
COVID Symptoms |
Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
Recognized by America's Top Doctors, 2015 - 2022
Recognized by Best Doctors in America, 2009 - 2012, 2015 - 2020
Recognized in Philadelphia magazine's annual Top Docs issues, 2011- 2022
Perelman Center for Advanced Medicine
West Pavilion, 1st Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
A recipient of a Masters degree in Clinical Epidemiology and Biostatistics, Dr. Kreider studies risk factors for both the development of Interstitial Lung Diseases and for poor outcome. She is an active participant in several drug trials for patients both with pulmonary fibrosis and sarcoidosis. In addition she participates in studies of patients with Lymphangioleiomyomatosis (LAM).
Winterbottom CJ, Shah RJ, Patterson KC, Kreider ME, Panettierri RA Jr, Rivera-Lebron B, Miller WT, Litzky LA, Penning TM, Heinlen, Jackson T, Localio AR, Chritie JD: Exposure to ambient particulate matter is associated with accelerated functional decline in Idiopathic Pulmonary Fibrosis. Chest 153 (5): 1221-1228,2018.
Patterson KC, Shah RJ, Porteous MK, Christie JD, D'Errico C, Chadwick M, Triano M, Deshpande C, Rossman MD, Litzky LA, Kreider ME, Miller WT Jr: Interstitial Lung Disease in the Elderly Chest 151 (4): 838-844,2017.
George MD, Shah R, Kreider M, Miller WT Jr, Merkel PA, Werth VP.: Pulmonary function tests, interstitial lung disease, and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis. Br J Dermatol 176 (1): 262-264,2017.
Porteous MK, Rivera-Lebron BN, Kreider ME, Lee J, Kawut SM: Determinants of six-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation Pulm Circ 6 (1): 30-36,2016.
Kassutto SM, Dine CJ, Kreider M, Shah RJ: Changing the ambulatory training paradigm: design and implementation of an outpatient pulmonary fellowship curriculum Ann Am Thorac Soc 13 (4): 540-544,2016.
Kreider ME and Rossman MD.: Beryllium and Heard Metal Lung Disease Fishman's Textbook of Pulmonary Diseases and Disorders, 5th ed. : 1334-1341,2015.
Kreider ME: Pulmonary Function Testing Scientific American Medicine [online] : 2014.
Kreider M, Highland K: Pulmonary Involvement in Sjogren's Syndrome Semin Respir Crit Care Med 35 (2): 255-264,2014.
Kreider, M: Lung Cancer in Idiopathic Pulmonary Fibrosis Curr Respir Care Rep 2 (4): 248-253,2013.
Dine, CJ, Kreider, ME: Pulmonary Complication of Collagen Vascular Diseases Clinical Decision Support: Pulmonary and Sleep Medicine - www.decisionsupportinmedicine.com/DSM/a/templates/28 (accessed April 16, 2013) : 2013.
Rivera-Lebron BN, Forfia P, Kreider M, Lee J, Holmes J, Kawut SM.: Echocardiographic and Hemodynamic Predictors of Mortality in Idiopathic Pulmonary Fibrosis Chest 144 (2): 564-570,2013.
Song G, Barbosa EM, Tustison ND, Gefter WB, Kreider ME, Gee JC, Torigian DA: Comparative Study of HRCT Image Metrics and PFT Values for Characterization of ILD and COPD. Academic Radiology 19 (7): 857-64,2012.
Kreider ME, Hadjiliadis D, Kotloff RM: Candidate Selection, Timing of Listing, and Choice of Procedure for Lung Transplantation. Clinics in Chest Medicine 32 (2): 199-211,2011.
Barbosa EM, Song G, Tustison N, Kreider ME, Gee J, Gefter WB, Torigian DA.: Computational Analysis of Thoracic Multidetector Row HRCT for Segmentation and Quantification of Small Airway Trapping and Emphysema for Obstructive Pulmonary Disease. Academic Radiology 18 : 1258-1269,2011.
Munson JC, Kreider ME, Chen Z, Christie JD, Kimmel SE: Use of Corticosteroids and Cytotoxic Agents in the Initial Management of IPF: Effect of Treatment Guidelines Over Time. British Journal of Clinical Pharmacology 70 (1): 118-125,2010.
Morganroth PA, Kreider ME, Werth VP: Interstitial Lung Disease in Classic and Amyopathic Dermatomyositis: a Retrospective Study with Screening Recommendations. Archives of Dermatology 146 (7): 729-738,2010.
Morganroth PA, Kreider ME, Werth VP: Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis. Arthritis Care and Research 62 (10): 1496-1501,2010.
Munson JC, Kreider ME, Christie JD, Kimmel SE: The Effect of Treatment Guidelines on the Initial Management of Idiopathic Pulmonary Fibrosis Pharmacoepidemiology and Drug Safety 18 (Suppl 1): S144-145,2009.
Munson JC, Kreider ME, Chen SA, Christie J, and Kimmel, SE: Factors Associated with Corticosteroid Therapy in Idiopathic Pulmonary Fibrosis American Journal Respiratory and Critical Care Medicine 179 (1): A4050,2009.
Munson JC, Kreider ME, Tino G: Idiopathic Pulmonary Fibrosis BMJ Point-of-Care - www.pointofcare.bmj.com (Last accessed 10/2009) : 2009.
Kreider ME, Hansen-Flaschen J, Ahmad NN, Rossman MD, Kaiser LR, Kucharczuk JC, Shrager JB: Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. The Annals of Thoracic Surgery 83 (3): 1140-4,2007.
Lange NE, Mulholland M, Kreider ME: Spirometry: Don't Blow It! Chest 136 (2): 608-14,2009.
Hospital of the University of PennsylvaniaPulmonary, Allergy and Critical Care Medicine Division838 Gates Bldg
Patient appointments: 800-789-7366